Not finding it? Sign in to also search OpenAlex live.
-
Health-Related Quality of Life in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Data from the Perseus Trial of Subcutaneous Daratumumab Combined with Bortezomib, Lenalidomide, and Dexamethasone (D-VRd)
Pieter Sonneveld, Meletios Athanasios Dimopoulos, Mario Boccadoro, Hang Quach, Phoebe Joy Ho, Meral Beksaç, +38 more
1citations -
Neuroimaging Biomarkers of Neuroprotection: Impact of Voluntary versus Enforced Exercise in Alzheimer’s Disease Models2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Dementia and Cognitive Impairment Research Open access
Alexandra Badea, Ali Mahzarnia, Divya Reddy, Zijian Dong, Robert J. Anderson, Hae Sol Moon, +4 more
0citations -
A synthetic 3D human cerebrovascular model informed by histology for simulating the cortical depth-dependent BOLD fMRI signal2026 PLoS Computational Biology article Medicine Advanced MRI Techniques and Applications Open access
Mario Gilberto Báez‐Yáñez, Jeroen C.W. Siero, Matthias J.P. van Osch, Natalia Petridou
0citations -
Health-related quality of life (HRQoL) in patients with newly diagnosed multiple myeloma (NDMM) eligible for transplantation and treated with isatuximab, lenalidomide, bortezomib, and dexamethasone (Isa-RVd) versus rvd alone: Results from part 1 of the GMMG-HD7 study
Roland Schroers, Lisa Beatrice Leypoldt, Christof Scheid, Evgenii Shumilov, Christoph Lutz
0citations